SHPH supply chain intelligence for Shuttle Pharmaceuticals Holdings, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| 1542770-BC-LTD | 1542770-BC-LTD | 92% | Pursuant to the terms and conditions of the Second Amendment, on the Effective Date, the Acquiror (i) issued 270 shares of Series B-1 Convertible Preferred Stock to Seller (such shares, the "Seller B… |
| E-F-HUTTON-CO | E-F-HUTTON-CO | 92% | In connection with the Merger, the Acquiror issued to E.F. Hutton & Co. (i) 750 shares of Series B-1 Preferred Stock convertible, subject to Requisite Approval, into 3,024,749 shares of Acquiror Comm… |
| IR-AGENCY | IR-AGENCY | 92% | As consideration for the performance of the Services, the Company paid IR Agency $1.5 million. |
| IR-AGENCY-LLC | IR-AGENCY-LLC | 92% | As consideration for the performance of the services, the Company paid $ 1.25 million to IR Agency. |
| ZHITIAN-ANDY-ZHANG | ZHITIAN-ANDY-ZHANG | 92% | Pursuant to the terms and conditions of the Second Amendment, on the Effective Date, the Acquiror (i) issued 270 shares of Series B-1 Convertible Preferred Stock to Seller (such shares, the "Seller B… |
| 1542770-B-C-LTD | 1542770-B-C-LTD | 90% | In exchange for the acquired assets, the Company agreed to pay the Selling Parties (i) a cash payment of $ 3,000,000 at Closing, (ii) a first installment of $ 3,000,000 payable six months after Closi… |
| 1563868-B-C-LTD | 1563868-B-C-LTD | 90% | Pursuant to the terms and conditions of the Second Amendment, on the Effective Date, the Acquiror (i) issued 270 shares of Series B-1 Convertible Preferred Stock to Seller (such shares, the "Seller B… |
| ALTO-OPPORTUNITY-MASTER-FUND-SPC-SEGREGATED-MAST | ALTO-OPPORTUNITY-MASTER-FUND-SPC-SEGREGATED-MAST | 90% | Amendment No. 1 to the Amendment Agreement, dated June 4, 2023, by and between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Pharmaceuticals, Inc. and Alto Opportunity Master Fund, SPC – Segregated… |
| BROWN-UNIVERSITY-LIFESPAN-RHODE-ISLAND-HOSPITAL | BROWN-UNIVERSITY-LIFESPAN-RHODE-ISLAND-HOSPITAL | 90% | Subcontract to Brown University/LifeSpan Rhode Island Hospital. |
| GEORGETOWN-UNIVERSITY | GEORGETOWN-UNIVERSITY | 90% | 10.52 License Agreement, dated October 24, 2023, by and between Shuttle Pharmaceuticals Holdings, Inc. and Georgetown University |
| SRO-LLC | SRO-LLC | 90% | 10.54 Securities Purchase Agreement, dated February 7, 2024, between Shuttle Pharmaceuticals Holdings, Inc., Shuttle Diagnostics, Inc. and SRO LLC |
| THERADEX-SYSTEMS-INC | THERADEX-SYSTEMS-INC | 80% | the Company received a letter from Theradex Systems, Inc., providing written notice of termination of the master agreement |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| 1563868-B-C-LTD | 1563868-B-C-LTD | 92% | Shuttle Pharmaceuticals Holdings, Inc. entered into a First Amendment to Asset Purchase Agreement with 1563868 B.C. Ltd., a Canadian limited corporation and the Company’s wholly owned subsidiary |
| SHUTTLE-MERGER-SUB-INC | SHUTTLE-MERGER-SUB-INC | 92% | On May 6, 2026 (the " Closing Date "), Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (" Shuttle " or " Acquiror "), completed its previously announced merger pursuant to an Agreement… |
| UNITED-DOGECOIN-INC | UNITED-DOGECOIN-INC | 92% | On May 6, 2026 (the " Closing Date "), Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (" Shuttle " or " Acquiror "), completed its previously announced merger pursuant to an Agreement… |
| CERTAIN-ACCREDITED-INVESTORS | CERTAIN-ACCREDITED-INVESTORS | 90% | As previously announced, on April 30, 2026, the Acquiror entered into a Securities Purchase Agreement (the " Securities Purchase Agreement ") with certain accredited investors party thereto (each, a … |
| ALTERNATIVE-INVESTMENT-CAPITAL-INC | ALTERNATIVE-INVESTMENT-CAPITAL-INC | 62% | arising from breaches of representations, warranties, and covenants and specified pre-/post-closing liabilities, subject to customary limitations such as survival periods, thresholds, and caps. The t… |
| B-C-LTD | B-C-LTD | 62% | ent or in information provided pursuant to certain disclosure schedules to the Merger Agreement. In the Merger Agreement, the Company made certain customary representations to Acquiror including amon… |
| BC-LTD | BC-LTD | 62% | ent or in information provided pursuant to certain disclosure schedules to the Merger Agreement. In the Merger Agreement, the Company made certain customary representations to Acquiror including amon… |
| COMPANY-SHUTTLE-DIAGNOSTICS-INC | COMPANY-SHUTTLE-DIAGNOSTICS-INC | 62% | 3,992,675 Proceeds from issuance of common stock and pre-funded warrants, net of placement agent costs of $ 322,501 5,409,673 — Proceeds from issuance of common stock and pre-funded warrants, net of … |
| IR-AGENCY-LLC | IR-AGENCY-LLC | 62% | shares of common stock, with an exercise price of $ 3.38 per share, as adjusted, valued at inception at $ 1.1 million and as of December 31, 2025, at less than $ 0.1 million. The Company determined t… |
| SHUTTLE-PHARMA-ACQUISITION-CORP-INC | SHUTTLE-PHARMA-ACQUISITION-CORP-INC | 62% | S FROM INVESTING ACTIVITY: Payments made for capitalized software ( 36,000 ) — Net cash used in investing activity ( 36,000 ) — CASH FLOWS FROM FINANCING ACTIVITIES: Repayment of note payable-related… |
| SHUTTLE-PHARMACEUTICALS-INC | SHUTTLE-PHARMACEUTICALS-INC | 62% | S FROM INVESTING ACTIVITY: Payments made for capitalized software ( 36,000 ) — Net cash used in investing activity ( 36,000 ) — CASH FLOWS FROM FINANCING ACTIVITIES: Repayment of note payable-related… |
| SHUTTLE-PHARMACEUTICALS-LLC | SHUTTLE-PHARMACEUTICALS-LLC | 62% | S FROM INVESTING ACTIVITY: Payments made for capitalized software ( 36,000 ) — Net cash used in investing activity ( 36,000 ) — CASH FLOWS FROM FINANCING ACTIVITIES: Repayment of note payable-related… |
| WESTPARK-CAPITAL-INC | WESTPARK-CAPITAL-INC | 62% | arising from breaches of representations, warranties, and covenants and specified pre-/post-closing liabilities, subject to customary limitations such as survival periods, thresholds, and caps. The t… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| SHPH-DEBT-12521 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| SHPH-DEBT | Debt stack $91,021 | 90% | Market cache reports total debt of $91,021. |
| SHPH-DEBT-12520 | Warrants outstanding: 329461 | 90% | xbrl warrant detail from xbrl 2026-02-28. |
| Acquired Entity | Name | Confidence | Evidence |
|---|---|---|---|
| SHPH-ACQ-0001493152-26-020830 | The Acquiror entered into a Securities Purchase Agreement to issue $11,000,000 of Series B-2 con... | 85% | The Acquiror entered into a Securities Purchase Agreement to issue $11,000,000 of Series B-2 convertible preferred stock and warrants. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| SHPH-OWNER-BARCLAYS-PLC | BARCLAYS PLC | 90% | 13F overlay lists BARCLAYS PLC as top holder; 1 tracked holders. |